| Literature DB >> 16784522 |
Fiona J Thompson1, Gary L A Barker, Louise Hughes, Clare P Wilkes, Jane Coghill, Mark E Viney.
Abstract
BACKGROUND: The nematode Strongyloides ratti has two adult phases in its lifecycle: one obligate, female and parasitic and one facultative, dioecious and free-living. The molecular control of the development of this free-living generation remains to be elucidated.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16784522 PMCID: PMC1525192 DOI: 10.1186/1471-2164-7-157
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1The life-cycle of S. ratti with two discrete developmental switches, shown as grey boxes: (1) a sex determination event and (2) a female-only developmental switch. L, denotes larval stages, as numbered. An adult parasitic female (top) and free-living adult female (bottom) are shown; bars = 100 μM. After [4].
The number of ESTs, contigs and clusters differently expressed in L1 and iL3 stages and those with a two-fold or greater difference in expression.
| 659 | 1,244 | 1,903 | |
| 217 | 147 | 364 | |
| 192 | 796 | 988 | |
| 50 | 69 | 119 | |
| 166 | 770 | 936 | |
| 37 | 62 | 99 |
1These ESTs are represented by 203 and 178 (L1-up) and 817 and 793 (iL3-up) contigs and clusters respectively.
2Number of ESTs that have a ratio of expression that is ≥ 2; these ESTs are represented by 72 and 60 (L1-up) and 82 and 75 (iL3-up) contigs and clusters respectively.
3 Number of contigs or clusters, respectively, in which at least one EST member (for which there were data above the quality threshold) had a significantly different ratio of expression.
4Number of contigs or clusters, respectively, in which at least one EST member (for which there were data above the quality threshold) has a significantly different ratio of expression that is ≥ 2.
Reverse transcriptase-PCR analysis of the expression of clusters and contigs differentially expressed between the L1 and iL3s stages.
| SR00369 | 3.6 | SR01101 | 3.89 | 0.84 (0) |
| SR00073 | 2.46 | SR01013 | 2.46 | 1.02 (0) |
| SR00647 | 3.68 | SR00647 | 3.68 | 3.13 (3.7) |
| SR00369 | 3.6 | SR01099 | 3.1 | 4.34 (4.2) |
| SR00001 | 2.83 | SR00001 | 5.82 | 4.18 (0.2) |
| SR00369 | 3.6 | SR01100 | 5.82 | 1.7 (1.0) |
| SR00762 | 3.2 | SR00762 | 3.2 | 18.7 (0.14) |
| SR00369 | 3.6 | SR00853 | 4.24 | 5.74 (6.6) |
| SR00222 | 4.46 | SR00222 | 4.45 | 18.3 (5.8) |
| SR03050 | 3.51 | SR03050 | 3.51 | 2.69 (2.3) |
| SR01720 | 2.93 | SR01720 | 2.93 | 9.7 (3.9) |
| SR00448 | 2.60 | SR00448 | 2.59 | 9.6 (12.5) |
| SR01335 | 2.22 | SR01335 | 2.22 | 3.63 (4.0) |
| SR00906 | 2.06 | SR00906 | 2.06 | 3.39 (2.8) |
| SR02481 | 1.85 | SR02481 | 1.85 | 7.61 (0.71) |
| SR01791 | 1.64 | SR01791 | 1.64 | 2.4 (1.3) |
| SR00681 | 1.52 | SR00681 | 1.52 | 4.3 (3.7) |
| SR01787 | 1.42 | SR01787 | 1.42 | 2.72 (3.7) |
| SR00322 | 1.16 | SR00322 | 1.16 | 8.08 (9.6) |
| SR00163* | 1.91 | SR00785 | 3.12 | 0.89 (0.12) |
| SR00113* | 1.54 | SR00113 | - | 0.99 (0.15) |
1Mean cluster and contig fold difference in expression between L1 and iL3 stages measured by microarrays for iL3-up (normal text) and L1-up (bold text) clusters and contigs and for reference genes (*); – indicates that there were no significant data generated for this contig.
2The mean (SD) fold difference in expression as measured by RT-PCR is calculated as iL3s/L1 for iL3-up (normal text) contigs and clusters and L1/iL3 for L1-up (bold text) clusters and contigs and for the reference genes (*).
The 62 iL3-up clusters (Table 1) showing the mean cluster fold change between iL3 and L1 stages, the most significant BLAST alignment and the GO slim terms, arranged by descending iL3 : L1 difference in expression.
| SR00272 | 21.86 | -4 | - | - | -4 | - | - |
| SR02119 | 9.45 | - | - | - | - | - | - |
| SR01748 | 4.66 | 1.00E-13 | Y25C1A.3 | - | - | - | |
| SR00222 | 4.46 | - | - | - | - | - | - |
| SR02762 | 4.29 | 5.00E-14 | B0213.17 | - | - | - | |
| SR00107 | 3.97 | 4.00E-28 | F33D4.2f | rhythmic behaviour, muscle contraction, defecation | inositol-1-,4-,5-triphosphate receptor activity | membrane, endoplasmic reticulum | |
| SR01733 | 3.78 | - | - | - | - | - | - |
| SR00647 | 3.68 | 1.00E-79 | F54C1.7 | - | calcium ion binding | - | |
| SR02628 | 3.63 | 6.00E-46 | F42D1.2 | L-phenylalanine catabolism, tyrosine catabolism | tyrosine transaminase activity | unknown | |
| SR00369 | 3.60 | 1.00E-58 | C32D5.9 | protein targeting | tubulin binding | plasma membrane | |
| SR03050 | 3.51 | 9.00E-28 | TBN95TM-SSR | - | - | - | |
| SR01141 | 3.46 | 2.00E-25 | F08F1.8 | - | - | - | |
| SR01368 | 3.34 | 2.00E-11 | W06A7.3e | - | unknown | - | |
| SR01871 | 3.29 | 6.00E-08 | F11C7.3b | unknown | unknown | endoplasmic reticulum | |
| SR00762 | 3.20 | 5.00E-81 | ZC8.4b | - | motor activity | non-muscle myosin | |
| SR01845 | 3.18 | 1.00E-08 | XP_358683 | - | - | - | |
| SR03037 | 3.16 | 3.00E-41 | C40H1.5 | - | unknown | - | |
| SR01142 | 3.05 | 9.00E-61 | ZK973.10 | embryogenesis and morphogenesis, larval development | - | - | |
| SR02353 | 3.05 | 2.00E-05 | TBN95TM-SSFH | - | - | - | |
| SR00386 | 3.00 | - | - | - | - | - | - |
| SR01720 | 2.93 | 2.00E-17 | ZK270.2d | - | - | - | |
| SR01943 | 2.87 | 4.00E-17 | NK7 | - | - | - | |
| SR00001 | 2.83 | 2.00E-10 | TBN95TM-SSR | - | - | - | |
| SR02086 | 2.77 | 6.00E-11 | NK | - | - | - | |
| SR00424 | 2.73 | - | - | - | - | - | - |
| SR02886 | 2.71 | 3.00E-74 | ZK1073.1 | spermatogenesis, cell differentiation, negative regulation of cell growth | unknown | - | |
| SR02990 | 2.68 | 3.00E-15 | F02A9.2 | - | - | - | |
| SR03016 | 2.64 | 9.00E-05 | R07H5.10 | - | - | - | |
| SR00448 | 2.60 | 3.00E-63 | F46A9.5 | embryogenesis and morphogenesis, reproduction | - | - | |
| SR00092 | 2.53 | 3.00E-08 | F55F8.6 | - | - | - | |
| SR02874 | 2.50 | 4.00E-05 | TBN95TM-SSFH | - | - | - | |
| SR00073 | 2.46 | 2.00E-26 | Y43F8B.1a | - | - | - | |
| SR00604 | 2.46 | 4.00E-15 | Y106G6H.2a | regulation of protein activity, epigenetic | - | - | |
| SR01164 | 2.43 | 2.00E-06 | TBN95TM-SSFH | - | - | - | |
| SR02266 | 2.39 | 2.00E-23 | R02F2.8 | - | - | - | |
| SR00717 | 2.39 | 4.00E-72 | R53.4 | - | - | - | |
| SR01779 | 2.36 | 7.00E-17 | M60.7 | - | - | - | |
| SR02390 | 2.36 | - | - | - | - | - | - |
| SR00889 | 2.34 | 8.00E-76 | H22K11.1 | induction of non-apoptotic programmed cell death, proteolysis and peptidolysis | aspartic-type endopeptidase activity | lysosome | |
| SR00607 | 2.34 | 2.00E-99 | F02E8.1 | embryogenesis and morphogenesis | - | - | |
| SR00704 | 2.29 | 5.00E-54 | E04A4.7 | - | - | - | |
| SR01197 | 2.29 | 3.00E-11 | W01F3.3 | - | - | - | |
| SR00813 | 2.29 | 2.00E-65 | F42G4.3a | cell adhesion, signal transduction, cell-cell signalling | - | integral to plasma membrane | |
| SR01881 | 2.28 | 9.00E-52 | Y40B10A.2 | - | - | - | |
| SR00998 | 2.27 | 3.00E-91 | C36E6.5 | regulation of striated muscle contraction, regulation of muscle contraction | structural constituent of muscle | cytoskeleton | |
| SR00241 | 2.27 | 4.00E-114 | Y105E8B.1a | regulation of muscle contraction | unknown | cytoskeleton, cytoskeleton | |
| SR00192 | 2.25 | 1.00E-38 | T03D8.3 | - | GTP binding, enzyme activator activity | secretory vesicle | |
| SR02882 | 2.25 | 1.00E-93 | F48F7.1 | embryonic development, larval development | unknown | - | |
| SR01335 | 2.22 | 4.00E-18 | F25H2.9 | - | - | 26S proteasome | |
| SR00164 | 2.21 | 3.00E-71 | Y37D8A.14 | - | cytochrome-c oxidase activity, electron transporter activity | - | |
| SR00231 | 2.18 | - | - | - | - | - | - |
| SR00903 | 2.18 | 9.00E-78 | TBN95TM-SSFH | - | - | - | |
| SR01737 | 2.17 | 6.00E-09 | TBN95TM-SSFH | - | - | - | |
| SR02037 | 2.17 | 8.00E-42 | F10C1.2a | - | - | lamin filament | |
| SR02982 | 2.17 | 4.00E-38 | Y105E8A.19 | tyrosyl-tRNA aminoacylation, apoptosis, cell motility, protein biosynthesis | tyrosine-tRNA ligase activity, signal transducer activity, interleukin-8 receptor binding | soluble fraction | |
| SR02952 | 2.16 | 3.00E-41 | K07E1.1 | - | - | - | |
| SR00038 | 2.13 | 7.00E-26 | F25B5.4a | proteolysis and peptidolysis, protein metabolism | - | ribosome | |
| SR02710 | 2.11 | 7.00E-38 | Y59A8B.23 | protein amino acid phosphorylation, response to stress | receptor signalling protein serine/threonine kinase activity, ATP binding | - | |
| SR00308 | 2.09 | 4.00E-18 | B0365.3 | - | sodium/potassium-exchanging ATPase activity | membrane fraction | |
| SR00918 | 2.09 | 4.00E-13 | F52D10.3a | chromosome segregation, learning and/or memory, olfactory learning | protein kinase C inhibitor activity | - | |
| SR00906 | 2.06 | 7.00E-84 | Y53G8AR.3 | - | - | - | |
1The mean cluster iL3 : L1 difference in expression.
2The most significant BLAST alignment for each cluster, the BLAST score, E, and GenBank accession number.
3Gene ontology slim term, [52].
4- = no alignment or assignment, as appropriate.
5Ce, C. elegans; Mm, Mus musculus; Ov, Onchocerca volvulus; Pt, Parastrongyloides trichosuri; Ss, Strongyloides stercoralis.
6hypo prot – hypothetical protein; predicted – ORF predicted by GeneFinder in WormBase [53]; partially confirmed – partial sequence cloned; confirmed – full-length sequence cloned.
7NK, not known.
The 37 L1-up clusters (Table 1) showing the mean cluster fold change between L1 and iL3 stages, the most significant BLAST alignment and the GO slim terms, arranged by descending L1 : iL3 difference in expression.
| SR01196 | 3.65 | 2.00E-16 | Y34B4A.6 | -6 | - | - | |
| SR00880 | 3.13 | 4.00E-28 | B0412.4 | embryogenesis & morphogenesis | - | ribosome | |
| SR01112 | 2.87 | -6 | - | - | - | - | - |
| SR00783 | 2.78 | 2.00E-33 | F37C12.11 | protein biosynthesis | constituent of ribosome | ribosome | |
| SR00048 | 2.77 | 2.00E-39 | Y106G6H.3 | - | - | - | |
| SR02498 | 2.77 | - | - | - | - | - | - |
| SR00689 | 2.64 | 7.00E-17 | C06B8.8 | protein biosynthesis | RNA binding, constituent of ribosome | ribosome | |
| SR02484 | 2.57 | - | - | - | - | - | - |
| SR01003 | 2.54 | 1.00E-79 | F37C12.9 | protein biosynthesis & metabolism | - | ribosome | |
| SR01012 | 2.50 | 8.00E-67 | F36A2.6 | embryogenesis & morphogenesis | - | - | |
| SR00216 | 2.43 | 2.00E-33 | C14A4.1 | embryogenesis & morphogenesis | - | phycobilisome | |
| SR00059 | 2.38 | 4.00E-42 | D1007.6 | embryogenesis & morphogenesis | - | - | |
| SR00938 | 2.38 | 2.00E-37 | F10E7.7 | - | tRNA binding | - | |
| SR00178 | 2.35 | 7.00E-12 | VK10D6R.1 | - | - | - | |
| SR02516 | 2.35 | 3.00E-16 | P34546 | proton transport | - | integral to membrane | |
| SR00926 | 2.31 | 2.00E-76 | B0336.10 | protein biosynthesis & metabolism | - | ribosome | |
| SR00943 | 2.31 | 4.00E-44 | C04F12.4 | embryogenesis & morphogenesis | - | ribosome | |
| SR00211 | 2.30 | 4.00E-45 | W09C5.6a | protein biosynthesis | constituent of ribosome | ribosome | |
| SR00804 | 2.30 | 5.00E-62 | F40F11.1 | embryogenesis & morphogenesis | - | ribosome | |
| SR00871 | 2.30 | 6.00E-60 | F58B3.1 | - | - | - | |
| SR00951 | 2.28 | 1.00E-39 | W01D2.1 | - | - | - | |
| SR01225 | 2.28 | 3.00E-41 | C30C11.1 | protein biosynthesis | - | mitochondrial ribosome | |
| SR00012 | 2.27 | 1.00E-15 | F36A4.10 | - | - | - | |
| SR02773 | 2.27 | 1.00E-92 | P34346 | - | adenylate kinase activity | - | |
| SR01008 | 2.23 | 9.00E-61 | F39B2.6 | larval development | - | - | |
| SR01007 | 2.22 | 1.00E-111 | Y43B11AR.4 | protein biosynthesis | constituent of ribosome | ribosome | |
| SR00978 | 2.20 | 2.00E-80 | C16A3.9 | protein biosynthesis | constituent of ribosome | ribosome | |
| SR01030 | 2.20 | 3.00E-108 | T05E11.1 | protein biosynthesis | constituent of ribosome | ribosome | |
| SR00801 | 2.18 | 9.00E-53 | Y82E9BR.3 | - | - | integral to membrane | |
| SR00915 | 2.08 | 1.00E-18 | B0513.3 | protein biosynthesis | RNA binding, constituent of ribosome | ribosome | |
| SR01068 | 2.07 | 4.00E-110 | Y71F9AL.13a | protein biosynthesis | constituent of ribosome | ribosome | |
| SR02436 | 2.07 | 1.00E-57 | Q9U330 | dephosphorylation, phosphoinositide metabolism, dephosphorylation | inositol/phosphatidylinositol phosphatase activity | integral to golgi and endoplasmic reticulum membrane | |
| SR00026 | 2.06 | 2.00E-45 | Y37E3.7 | - | - | - | |
| SR00886 | 2.06 | 1.00E-32 | C42C1.14 | protein biosynthesis | constituent of ribosome | ribosome | |
| SR00811 | 2.04 | 9.00E-52 | Y105E8A.16 | protein biosynthesis & metabolism | - | ribosome | |
| SR00588 | 2.04 | 2.00E-76 | F57B7.3 | cuticle biosynthesis | constituent of cuticle | extracellular | |
| SR02281 | 2.00 | 3.00E-40 | Q21732 | - | - | - | |
1The mean cluster L1 : iL3 difference in expression.
2 The most significant BLAST alignment for each cluster, the BLAST score, E, and GenBank accession number.
3Gene ontology slim term, [52].
4 Ce: C. elegans
5hypo prot – hypothetical protein; predicted – ORF predicted by GeneFinder in WormBase [53]; partially confirmed – partial sequence cloned; confirmed – full-length sequence cloned.
6- = no assignment or alignment, as appropriate.
Figure 2The relationship between the log number of ESTs within a cluster and the observed mean cluster hybridization intensity for A) L1 and iL3 and B) L2-direct and – indirect microarray hybridization in which clusters containing more than 10 ESTs were grouped into three categories (11–25, 26–50 and > 51, nominally set as 25, 50 and 100, respectively) (○) and one >10 category, nominally set as 11 (■)).
The number of ESTs, contigs and clusters differently expressed in L2 direct and L2 indirect stages and those with a two-fold or greater difference in expression.
| 246 | 429 | 675 | |
| 1 | 4 | 5 | |
| 105 | 320 | 425 | |
| 1 | 2 | 3 | |
| 93 | 311 | 404 | |
| 1 | 2 | 3 |
1These ESTs are represented by 107 and 95 (L2 direct-up) and 323 and 316 (L2 indirect-up) contigs and clusters respectively.
2Number of ESTs that have a ratio of expression that is ≥ 2; these ESTs are represented by 1 (L2 direct-up) and 3 (L2 indirect-up) contigs and clusters respectively.
3Number of contigs or clusters, respectively, in which at least one EST member (for which there were data above the quality threshold) had a significantly different ratio of expression.
4Number of contigs or clusters, respectively, in which at least one EST member (for which there were data above the quality threshold) has a significantly different ratio of expression that is ≥ 2.
A summary of the three L2 clusters whose expression is significantly different between indirectly and directly developing L2s.
| SR02363 | 2.08 | 8.00E-17 | Y39B6A.1 | |
| SR00170 | 2.58 | 3.00E-05 | AAA29909.1 | |
| SR00374 | 2.02 | 1.00E-81 | R07E5.2 |
1The mean cluster difference in expression. L2 direct-up: SR02363. L2 indirect-up: SR00170, SR00374.
2The most significant BLAST alignment for each cluster, the BLAST score, E, and GenBank accession number.
3C. elegans hypothetical protein predicted by GeneFinder in WormBase [53]; partial sequence cloned.
4Conceptual translation of an Schistosoma mansoni sequence [54].
Reverse transcriptase-PCR analysis of the expression of clusters and contigs differentially expressed between the directly and indirectly developing L2s.
| SR02363 | 2.08 | SR02363 | 2.08 | 1.45 (0.46) |
| SR00009 | 1.69 | SR00027 | 1.69 | 0.76 (0.45) |
| SR00113 | 1.60 | SR00113 | 1.58 | 1.30 (0.67) |
| SR00113 | 1.60 | SR00987 | 1.63 | 1.21 (0.18) |
| SR00013 | 1.25 | SR00053 | 1.26 | 0.95 (0.48) |
| SR02856 | 1.48 | SR02856 | 1.48 | 2.69 (2.06) |
| SR00395 | 1.46 | SR00395 | 1.46 | 1.81 (2) |
| SR00012 | 1.40 | SR00989 | 1.45 | 0.66 (0.17) |
| SR00012 | 1.40 | SR00665 | 1.39 | 0.99 (0.59) |
| SR01030 | 1.39 | SR01030 | 1.39 | 1.09 (0.6) |
| SR00008 | 1.31 | SR00752 | 1.31 | 1.81 (1.01) |
| SR01870 | 1.34 | SR01870 | 1.34 | 1.59 (2.06) |
| SR00591 | 1.30 | SR00591 | 1.30 | 0.75 (0.33) |
| SR00012 | 1.40 | SR00955 | 1.28 | 1.30 (0.35) |
| SR00055 | 1.23 | SR00962 | 1.23 | 0.97 (0.14) |
| SR00112 | 1.21 | SR00112 | 1.21 | 3.86 (5.72) |
| SR00950 | 1.18 | SR00950 | 1.18 | 1.46 (1.45) |
| SR01054 | 1.18 | SR01054 | 1.18 | 2.98 (3.91) |
| SR00611 | 1.16 | SR00611 | 1.16 | 4.38 (2.89) |
| SR00038 | 1.22 | SR00038 | 1.13 | 0.97 (0.51) |
| SR00205 | 1.01 | SR00205 | 1.01 | 0.38 (0.33) |
| SR00113* | 1.6 | SR00113 | 1.58 | 1.23 (0.87) |
| SR00015* | 1.1 | SR00015 | 1.1 | 0.25 (0.01) |
1Mean cluster and contig fold difference in expression between indirectly and directly developing L2 stages measured by microarrays for L2 direct-up (normal text) and L2 indirect-up (bold text) clusters and contigs and for reference genes (*).
2 The mean (SD) fold difference in expression as measured by RT-PCR is calculated as direct/indirect for the L2 direct-up (normal text) contigs and clusters and for the reference genes (*) and indirect/direct for the L2 indirect-up (bold text) contigs and clusters.
The expression of S. ratti genes with and without significant alignment to C. elegans genes with RNAi-knockdown phenotypes.
| 481 alignments | L1-up (1.18) | 0.0001 | |
| 1,422 no alignment | iL3-up (1.12) | ||
| 342 alignments | L1-up (1.26) | 0.0001 | |
| 1,561 no alignment | iL3-up (1.10) | ||
| 272 alignments | L1-up (1.22) | 0.001 | |
| 1,631 no alignment | iL3-up (1.09) | ||
| 187 alignments | L1-up (1.17) | 0.01 | |
| 1,716 no alignment | iL3-up (1.06) | ||
| 340 alignments | L1-up (1.16) | 0.001 | |
| 1,563 no alignment | iL3-up (1.09) | ||
| 1,622 alignments | L1-up (1.18) | 0.00001 | |
| 281 no alignment | iL3-up (1.16) |
1Number of S. ratti ESTs with or without significant BLAST alignment to C. elegans genes with RNAi phenotypes.
2The direction of the difference in expression (i.e. L1- or iL3-up) and, shown in parentheses, the mean ratio of expression.
3The significance of the difference of the mean levels of expression for the ESTs with and without significant BLAST alignments.
4All RNAi phenotypes combined. Note, that 511 S. ratti ESTs had significant alignment to a C. elegans gene that had an RNAi phenotype in more than one phenotypic class.
The expression of S. ratti contigs with and without significant alignment to S. stercoralis L1- or iL3- specific or – biased contigs.
| 114 alignments | iL3-up (1.23) | 0.001 | |
| 874 no alignment | L1-up (1.09) | ||
| 133 alignments | iL3-up (1.21) | 0.01 | |
| 855 no alignment | iL3-up (1.03) | ||
| 349 alignments | iL3-up (1.22) | 0.05 | |
| 639 no alignment | iL3-up (1.13) | ||
| 254 alignments | iL3-up (1.21) | 1.0 | |
| 734 no alignment | iL3-up (1.12) |
1Mitreva pers. comm. [17].
2Number of S. ratti contigs with or without a significant BLAST alignment to the S. stercoralis contigs in the respective categories.
3The direction of the difference in expression (i.e. L1- or iL3-up) and, shown in parentheses, the mean ratio of expression.
4The significance of the difference of the mean levels of expression for the ESTs with and without significant BLAST alignments.